Research Alliance Corp III (RACC) stock
RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.02+0.01 (+0.10%)
Close on Nov 20, 2026Market cap $91.17MP/E –Yield –
Research Alliance Corp III shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
No shares outstanding figures for Research Alliance Corp III
Research Alliance Corp III has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?